PKM and benign prostatic hyperplasia: In PCa cells (Du-145 and LNCaP), lincRNA-p21 suppressed cell development through inhibition of PKM2 [19], while clinical samples from patients with PCa had significant higher exosomal lincRNA-p21 levels than patients with BPH [17].